Jounce Therapeutics Appoints CFO
This article was originally published in Scrip
Jounce Therapeutics Inc., a company focused on novel cancer immunotherapies, has named Kim Drapkin chief financial officer (CFO). Before joining Jounce, Drapkin was the interim CFO for various biotech companies, including Jounce, through a financial consulting firm she owned. Prior to this she was CFO at EPIX pharmaceuticals and also spent 10 years at Millennium Pharmaceuticals in roles within the finance organisation.